Hodder to Lead Expanded Clinical and Translational Efforts at WVU

Facebook
Twitter
LinkedIn
Reddit
Tumblr
WhatsApp
Email

Sally L. Hodder, M.D., has been named associate vice president for clinical and translational research at West Virginia University, according to Clay Marsh, M.D., vice president and executive dean for health sciences.

Hodder currently serves as the director of the West Virginia Clinical and Translational Sciences Institute (WVCTSI), a statewide health research organization at WVU.

“Dr. Hodder’s responsibility will be to increase the quantity, quality and impact of research across WVU and throughout the state that has a positive impact on the health of West Virginians,” Dr. Marsh said. “She will identify new opportunities for collaboration among existing programs and implement new efforts to address important regional health issues.”

Clinical and translational research is aimed at discoveries that can be effectively used in hospitals and medical offices, other healthcare settings and communities to produce measurable changes in health. At WVCTSI, Hodder leads an effort to involve a broad range of health professionals and citizens across West Virginia in setting research agendas and carrying out research projects. In her new role, she will also work to enhance and broaden WVU’s existing relationships with community members and rural healthcare providers.

“I’m thrilled to be a part of Dr. Marsh’s leadership team. The opportunities for partnership that lie ahead in clinical and translational research at WVU and across West Virginia are truly energizing,” Hodder said. “As the state’s flagship land grant university, we are eager to work with West Virginia communities to improve our overall health.”

Hodder received her medical degree from Case Western Reserve University (CWRU) School of Medicine. Subsequently, Hodder was on the School of Medicine faculty at CWRU and then served as vice president of virology medical affairs at Bristol-Myers Squibb. She left Bristol-Myers Squibb in 2005 to return to academia and established an adult HIV clinical research program addressing disparate infection rates and HIV treatment outcomes amongst African-Americans compared with white individuals.

She has led WVCTSI since September 2014.

 

Leave a Reply

Your email address will not be published. Required fields are marked *

Post comment